| 5-LOX | 5-lipoxygenase |
| AD | Alzheimer’s disease |
| ADAS-Cog | Alzheimer’s disease assessment scale–cognitive subscale |
| ADCS | Activities of daily living scales |
| ALA | α linolenic acid |
| ApoE | apolipoprotein E |
| APP | amyloid precursor protein |
| ARA | arachidonic acid |
| Aβ | amyloid beta peptide |
| BADLS | Bristol’s activities of daily living scale |
| BASDEC | brief assessment schedule depression cards |
| BBB | blood–brain barrier |
| BDI | Beck depression inventory scale |
| CDR | clinical dementia rating scale |
| CGI | clinical global impression scale |
| CIBIC-Plus | clinician interview-based impression of change, plus carer interview |
| COX | cyclooxygenase |
| cPLA2 | cytosolic calcium-dependent phospholipase A2 |
| CSF | cerebrospinal fluid |
| DHA | docosahexaenoic acid |
| DHA-FFA | free nonesterified form docosahexaenoic acid |
| DSM-IV | Diagnostic and Statistical Manual of Mental Disorders, fourth edition |
| EPA | eicosapentaenoic acid |
| FABPs | fatty acid binding proteins |
| HDRS | Hamilton depression rating scale |
| hs-CRP | C-reactive protein |
| HVLT-R | Hopkins verbal learning test–revised |
| iPLA2 | cytosolic calcium-independent phospholipase A2 |
| LA | linoleic acid |
| LXA4 | lipoxin A4 |
| MADRS | Montgomery–Åsberg depression rating scale |
| MMSE | mini-mental state examination |
| MUFAs | monounsaturated fatty acids |
| NPI | Neuropsychiatric Inventory |
| NTB | neuropsychological test battery |
| PD | Parkinson’s disease |
| PKC | protein kinase C |
| PLA2 | phospholipase A2 |
| PUFAs | omega-3 polyunsaturated fatty acids |
| sPLA2 | secretory phospholipase A2 |
| RvD1 | resolvin D1 |
| TAC | total antioxidant capacity |
| UPDRS | unified Parkinson’s disease rating scale |